For instance, glioma stem cells, isolated from surgical samples, have been shown to downregulate MHC I molecules associated with an activation of the Wnt/β-catenin signaling pathway leading to evasion from CD8+ T cells [19,20]. The gene discussed is CD8A; the disease is central nervous system cancer.